300 companies
AMGN
AMGEN Inc.
Amgen Inc.
California
$164,663.6 mm
NASDAQ
GILD
Gilead Sciences, Inc.
Gilead Sciences, Inc.
California
$108,767.0 mm
NASDAQ
SGEN
Seagen Inc.
Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
Washington
$42,965.9 mm
NASDAQ
MRNA
Moderna Inc
moderna is pioneering messenger rna therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted.
Massachusetts
$38,006.4 mm
NASDAQ
BIIB
Biogen Inc
through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Massachusetts
$36,228.9 mm
NASDAQ
BNTX
BioNTech SE
everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases.
Germany
$23,355.5 mm
NASDAQ
ARGX
Argen X SE
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Belgium
$21,709.0 mm
NASDAQ
NBIX
Neurocrine Biosciences, Inc.
neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.
California
$13,498.8 mm
NASDAQ
TECH
Bio-Techne Corp
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities.
Minnesota
$11,125.9 mm
NASDAQ
XLRN
Acceleron Pharma Inc
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases.
Massachusetts
$10,931.6 mm
NASDAQ
QGEN
Qiagen NV
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights.
Netherlands
$10,289.6 mm
NYSE
RGEN
Repligen Corp.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs.
Massachusetts
$9,932.0 mm
NASDAQ
EXEL
Exelixis Inc
exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer.
California
$6,990.7 mm
NASDAQ
IMVT
Immunovant Inc
immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
New York
$5,840.0 mm
NASDAQ
PCVX
Vaxcyte Inc
sutrovax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases.
California
$5,771.1 mm
NASDAQ
ABCZF
Abcam plc
Abcam is a producer, distributor and seller of protein research tools.
United Kingdom
$5,500.2 mm
OTC
CRSP
CRISPR Therapeutics AG
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Switzerland
$4,921.6 mm
NASDAQ
HALO
Halozyme Therapeutics Inc.
we are a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment.
California
$4,509.8 mm
NASDAQ
RVMD
Revolution Medicines Inc
revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients.
California
$4,423.8 mm
NASDAQ
ALVO
Alvotech
alvotech was founded in 2013, with the clear mission to become a global leader in biogenerics, defined as differentiated, high-quality, cost-controlled biosimilars.
Luxembourg
$3,724.3 mm
NASDAQ